UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004496
Receipt number R000005109
Scientific Title A randomized phase II study of perioperable tiotropium treatment in gastric cancer patient with chronic obstructive pulmonary disease
Date of disclosure of the study information 2010/11/02
Last modified on 2013/11/05 11:56:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized phase II study of perioperable tiotropium treatment in gastric cancer patient with chronic obstructive pulmonary disease

Acronym

A randomized phase II study of tiotropium in gastric cancer with COPD

Scientific Title

A randomized phase II study of perioperable tiotropium treatment in gastric cancer patient with chronic obstructive pulmonary disease

Scientific Title:Acronym

A randomized phase II study of tiotropium in gastric cancer with COPD

Region

Japan


Condition

Condition

gastric cancer patient with COPD

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To analyze the efficacy and safety of perioperative tiotropium treatment for gastric cancer patients with COPD

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

reduction of FEV1.0 on POD14

Key secondary outcomes

pulmonaly mobidity rate, the number of days for O2 support after surgery


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration

Institution is not considered as adjustment factor.

Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

preoperative tiotropium for over 1 week and postoperative tiotropium for 2 weeks

Interventions/Control_2

Inharation of bromhexine/tyloxapol after surgery

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) histopathologically confirmed gastric cancer.
2) COPD patient, COPD stage I/II
3) no severe heart failure and arrithmia
4) preoperative day > 2 weeks
5) age of 20 years or older
6) Written informed consent

Key exclusion criteria

1) glaucoma
2) dysuria dur to BPH
3) allergy for atropine and tiotropium
4) Patient is diagnosis as asthma
5) clinically important infection or acute inflammation
6) psychological disease
7) patients who are judged to be ineligible by principal investigator for any other reason

Target sample size

84


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takashi Fujimura

Organization

Kanazawa University Hospital

Division name

Gastroenterologic Surgery

Zip code


Address

13-1 Takara-machi, Kanazwa

TEL

076-265-2362

Email

tphuji@staff.kanazawa-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Sachio Fushida

Organization

Kanazawa University Hospital

Division name

Gastroenterologic Surgery

Zip code


Address

13-1 Takara-machi, Kanazawa

TEL

076-265-2362

Homepage URL


Email

fushida@staff.kanazawa-u.ac.jp


Sponsor or person

Institute

NPO Digestive Disease Support Organization (DDSO)

Institute

Department

Personal name



Funding Source

Organization

NPO Digestive Disease Support Organization (DDSO)

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 11 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2010 Year 10 Month 01 Day

Last follow-up date

2013 Year 12 Month 31 Day

Date of closure to data entry

2013 Year 12 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 11 Month 02 Day

Last modified on

2013 Year 11 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005109


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name